EYE 4.55% 21.0¢ nova eye medical limited

CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-471

  1. 15,884 Posts.
    lightbulb Created with Sketch. 4140
    Thanks for sharing, to be fair though as a revenue generating business it's pretty easy to come up with a valuation. Just take the revenue ($28m run rate probably the best figure to use) and apply a typical multiple for a high growth rate company and you'll get between 50c - $1 as a conservative estimate (similar to what he came up with). Would be keen to know the exact methodology he used though as there are certainly a few methods that can be used here to find the fair value, and for a company like this you really want to use a method that focuses more on predicting future revenues and cashflows, than one that simply looks at the current revenue
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
-0.010(4.55%)
Mkt cap ! $48.10M
Open High Low Value Volume
22.5¢ 22.5¢ 21.0¢ $87.21K 406.3K

Buyers (Bids)

No. Vol. Price($)
9 400685 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 23537 2
View Market Depth
Last trade - 16.10pm 13/08/2024 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.